CompletedPhase 2

Triple Therapy Strategy for Managing Persistent Pain After Spinal Microdiscectomy

Egypt63 participantsStarted 2023-02-20

Plain-language summary

This interventional study evaluates a "triple therapy" approach-combining percutaneous spinal fixation, facet radiofrequency ablation, and epidural steroid/hyaluronidase injection-for patients with Failed Back Surgery Syndrome (FBSS). The study compares this combined strategy against spinal fixation alone to determine its effectiveness in reducing chronic radicular pain and disability.

Who can participate

Age range23 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with persistent back pain after microdiscectomy (FBSS). * Failure of conservative treatment for at least six months. * Positive results on a diagnostic lumbar facet nerve block. Exclusion Criteria: * Spinal instability, fractures, or spondylolisthesis. * Severe psychiatric disorders. * Baseline ODI score higher than 60%. * Opioid users or history of adverse reactions to steroids.

What they're measuring

Change in Pain Intensity (NRS)

Timeframe: 6 months post-intervention

Change in Disability Level (ODI)

Timeframe: 6 months post-intervention

Trial details

NCT IDNCT07370233

SponsorBenha University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-22

View on ClinicalTrials.gov More Spinal Disk Injury trials